RVPH
Reviva Pharmaceuticals Holdings Inc.

4,829
Mkt Cap
$60.8M
Volume
263,794.00
52W High
$4.28
52W Low
$0.2522
PE Ratio
-1.15
RVPH Fundamentals
Price
$0.5284
Prev Close
$0.5123
Open
$0.5104
50D MA
$0.5172
Beta
0.67
Avg. Volume
18M
EPS (Annual)
-$0.9026
P/B
11.19
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Brokers Offer Predictions for RVPH FY2025 Earnings
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH - Free Report) - Analysts at Chardan Capital issued their FY2025 earnings per share estimates for Reviva Pharmaceuticals in a research note issued...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
Bristol Myers' Cobenfy, the first new schizophrenia treatment in decades, shows early sales momentum and strong pipeline expansion potential.
Zacks·3mo ago
News Placeholder
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday
Earnings largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.
Stocktwits·1y ago
News Placeholder
Reviva Pharmaceuticals Launches Multi-Million Share Offering
The latest update is out from Reviva Pharmaceuticals Holdings (RVPH). Reviva Pharmaceuticals Holdings, Inc. has embarked on a financial maneuver wi...
TipRanks Financial Blog·1y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...
PR Newswire·2y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...
PR Newswire·2y ago
News Placeholder
RVPH INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH
RVPH INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH RVPH INVESTOR NOTICE...
PR Newswire·2y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...
PR Newswire·2y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...
PR Newswire·2y ago

Latest RVPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.